ArticleMedicine and pharmacy reports2025
Pembrolizumab-induced fulminant triple M syndrome presenting with severe bradycardia.
Maia Ioana Mihon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it